Second Generation Antipsychotic-Induced Obsessive-Compulsive Symptoms in Schizophrenia: A Review of the Experimental Literature
The DOI matches its Crossref record; 185 of the 186 references it cites were found in a registry or an index.
Abstract
Second generation antipsychotics (SGAs) have been implicated in the de novo emergence and exacerbation of obsessive-compulsive symptoms (OCS) in patients with schizophrenia. Among SGAs, clozapine, olanzapine, and risperidone are the most prominent agents associated with these sequelae, according to case reports. Comorbid OCS can impede recovery by compromising treatment benefits, medication compliance, and clinical prognoses. Previous reviews of SGA-induced OCS have predominantly focused on descriptive case reports, with limited attention paid toward experimental findings. To address this paucity of data, we sought to review the effects of SGAs on OCS in schizophrenia in the experimental literature, while addressing the role of different treatment (duration, dose, serum levels) and pharmacogenetic factors. Our findings suggest that clozapine confers the greatest risk of OCS in schizophrenia, with 20 to 28% of clozapine-treated patients experiencing de novo OCS, in addition to 10 to 18% incurring an exacerbation of pre-existing OCS. Clozapine can also yield full threshold obsessive-compulsive disorder (OCD), in some cases. Olanzapine is another high risk drug for secondary OCS which occurs in 11 to 20% of schizophrenic patients receiving olanzapine therapy. At this time, there is insufficient experimental evidence to characterize the effects of other SGAs on OCS. Despite some experimental support for the involvement of longer treatment duration and genetic factors in mediating drug-induced OCS, more research is needed to clearly elucidate these associations. Based on these results, schizophrenic patients should be routinely monitored for OCS throughout the course of SGA treatment, particularly when clozapine or olanzapine is administered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“despite the potential link of these medications with the occurrence of obsessive-compulsive symptoms.59”
From Cognitive Inflexibility Shares Across Schizophrenia and Obsessive-Compulsive Disorder: A Task-Based Functional MRI Study (2025) · cites this paper as [59]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,169
J Neuropsychiatry Clin Neurosci
Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818
The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication
Ruscio, A. M., Stein, D. J., Chiu, W. T., & Kessler, R. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.94 · Cited by 2,771
Genome-wide association analysis identifies 13 new risk loci for schizophrenia
Multicenter Genetic Studies of Schizophrenia Consortium, Ripke, S., Psychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2, O'Dushlaine, C., Chambert, K., Moran, J. L., Kähler, A. K., Akterin, S., Bergen, S. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2742 · Cited by 1,496
The Epidemiology of Obsessive-Compulsive Disorder in Five US Communities
Karno, M. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360042006 · Cited by 1,351
Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140
(2007) · PubMed · Cited by 953
(2008) · Cited by 889
Heritability Estimates for Psychotic Disorders: The Maudsley Twin Psychosis Series
Cardno, A. G., Marshall, E. J., Coid, B., Macdonald, A. M., Ribchester, T. R., Davies, N. J., Venturi, P., Jones, L. A., Lewis, S. W., Sham, P. C., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.2.162 · Cited by 797
Obsessive-compulsive disorder: An integrative genetic and neurobiological perspective
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3746 · Cited by 793
Kapur, S., Zipursky, R. B., & Remington, G. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.286 · Cited by 712
Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V, Bracken, M. B., & Leckman, J. F. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001823 · Cited by 635
McDougle, C. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040046006 · Cited by 570
Achim, A. M., Maziade, M., Raymond, E., Olivier, D., Merette, C., & Roy, M.-A. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp148 · Cited by 526
Epidemiology of schizophrenia: the global burden of disease and disability
Jablensky, A. (2000) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060070002 · Cited by 460 · cited 1×
“acterized by a chronic course, and according to diagnostic systems, a global lifetime prevalence rate in the range of 1-4 cases per 1000 persons [1–3].”
BackgroundReasoning, Emotions, and Delusional Conviction in Psychosis.
Garety, P. A., Freeman, D., Jolley, S., Dunn, G., Bebbington, P. E., Fowler, D. G., Kuipers, E., & Dudley, R. (2005) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.114.3.373 · Cited by 436
Pittenger, C., Bloch, M. H., & Williams, K. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.006 · Cited by 426
Kapur, S. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.6.553 · Cited by 396
Zohar, J. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800230026006 · Cited by 370
5-HT2and D2Receptor Occupancy of Olanzapine in Schizophrenia: A PET Investigation
Kapur, S., Zipursky, R. B., Remington, G., Jones, C., DaSilva, J., Wilson, A. A., & Houle, S. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.7.921 · Cited by 370
Stein, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09620-4 · Cited by 352
Fullana, M. A., Mataix-Cols, D., Caspi, A., Harrington, H., Grisham, J. R., Moffitt, T. E., & Poulton, R. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08071006 · Cited by 308
The Global Prevalence of Schizophrenia
Bhugra, D. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020151 · Cited by 287 · cited 2×
“acterized by a chronic course, and according to diagnostic systems, a global lifetime prevalence rate in the range of 1-4 cases per 1000 persons [1–3].”
BackgroundBeyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?
Goodman, W. K., McDougle, C. J., Price, L. H., Riddle, M. A., Pauls, D. L., & Leckman, J. F. (1990) · PubMed · Cited by 283
Dimensional Approach to Delusions: Comparison Across Types and Diagnoses
Appelbaum, P. S., Robbins, P. C., & Roth, L. H. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1938 · Cited by 268
Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response
Arranz, M. J., Munro, J., Sham, P., Kirov, G., Murray, R. M., Collier, D. A., & Kerwin, R. W. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00032-2 · Cited by 255
Nyberg, S., Eriksson, B., Oxenstierna, G., Halldin, C., & Farde, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.869 · Cited by 251
In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems
MELTZER, H., & HUANG, M. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00909-6 · Cited by 248
Denys, D., de Geus, F., van Megen, H. J. G. M., & Westenberg, H. G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0803 · Cited by 248
Mamo, D., Graff, A., Mizrahi, R., Shammi, C. M., Romeyer, F., & Kapur, S. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06091479 · Cited by 242
Charney, D. S. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260095012 · Cited by 242
Bystritsky, A., Ackerman, D. L., Rosen, R. M., Vapnik, T., Gorbis, E., Maidment, K. M., & Saxena, S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0418 · Cited by 220
Dold, M., Aigner, M., Lanzenberger, R., & Kasper, S. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000740 · Cited by 211
Veale, D., & Roberts, A. (2014) · BMJ · doi:10.1136/bmj.g2183 · Cited by 206
Swets, M., Dekker, J., van Emmerik-van Oortmerssen, K., Smid, G. E., Smit, F., de Haan, L., & Schoevers, R. A. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.033 · Cited by 201
Obsessive compulsive disorder with psychotic features.
Eisen, J. L., & Rasmussen, S. A. (1993) · PubMed · Cited by 198
Obsessive and compulsive symptoms in chronic schizophrenia
Berman, I., Kalinowski, A., Berman, S. M., Lengua, J., & Green, A. I. (1995) · Comprehensive Psychiatry · doi:10.1016/0010-440x(95)90092-a · Cited by 198 · cited 2×
“Most studies have found that schizophrenic patients with comorbid OCS experience higher rates of positive [9, 48–51] and negative symptoms [10, 48, 51, 52], earlier age of psychosis onset [53], longer illness duration [53], use of more extensive clinical treatments [52], and longer and more frequent hospitalizations […”
BackgroundObsessive-Compulsive Disorder in Patients With First-Episode Schizophrenia
Poyurovsky, M., Fuchs, C., & Weizman, A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1998 · Cited by 197
Bottas, A., Cooke, R. G., & Richter, M. A. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0527 · Cited by 196
Self-citationObsessive-compulsive disorder in the community: an epidemiologic survey with clinical reappraisal
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.8.1120 · Cited by 195
5-HT2A promoter polymorphism −1438G/A, anorexia nervosa, and obsessive-compulsive disorder
Enoch, M.-A., Kaye, W. H., Rotondo, A., Greenberg, B. D., Murphy, D. L., & Goldman, D. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78746-8 · Cited by 192
Obsessive–compulsive symptoms induced by atypical antipsychotics. A review of the reported cases
Lykouras, L., Alevizos, B., Michalopoulou, P., & Rabavilas, A. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00039-3 · Cited by 190 · cited 1×
“In fact, case reports most frequently implicate clozapine, olanzapine, and risperidone in mediating secondary OCS [4] which are phenomenologically similar to OCS in primary obsessive-compulsive disorder (OCD) [5].”
BackgroundObsessive-compulsive disorder with poor insight
Matsunaga, H., Kiriike, N., Matsui, T., Oya, K., Iwasaki, Y., Koshimune, K., Miyata, A., & Stein, D. J. (2002) · Comprehensive Psychiatry · doi:10.1053/comp.2002.30798 · Cited by 189
Mamo, D., Kapur, S., Shammi, C. M., Papatheodorou, G., Mann, S., Therrien, F., & Remington, G. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.818 · Cited by 188
Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap.
Tibbo, P. G., & Warneke, L. B. (1999) · PubMed · Cited by 173
Obsessive–compulsive disorder in schizophrenia
Tibbo, P., Kroetsch, M., Chue, P., & Warneke, L. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00048-5 · Cited by 172 · cited 1×
“In some studies, OCS comorbidity has been argued to have a protective effect against positive and negative symptoms, particularly within first-episode patients [12, 46, 47].”
BackgroundHeyman, I. (2006) · BMJ · doi:10.1136/bmj.333.7565.424 · Cited by 166
Abbruzzese, M., Bellodi, L., Ferri, S., & Scarone, S. (1995) · Brain and Cognition · doi:10.1006/brcg.1995.1017 · Cited by 164
Obsessive–compulsive disorder in hospitalized patients with chronic schizophrenia
Poyurovsky, M., Hramenkov, S., Isakov, V., Rauchverger, B., Modai, I., Schneidman, M., Fuchs, C., & Weizman, A. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00238-4 · Cited by 161 · cited 1×
“These worsened outcomes have been shown to lead to greater functional impairment in the areas of increased social isolation [9], and lower levels of the following: social functioning [11, 63], marriage and cohabitation [14], and independent living, employment, and ageappropriate functioning [9, 14, 42, 49, 52].”
BackgroundHanna, G. L., Himle, J. A., Curtis, G. C., Koram, D. Q., Veenstra-VanderWeele, J., Leventhal, B. L., & Cook, E. H. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00097-3 · Cited by 160
BERMAN, I., MERSON, A., VIEGNER, B., LOSONCZY, M. F., PAPPAS, D., & GREEN, A. I. (1998) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199803000-00003 · Cited by 159
Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.271 · Cited by 156 · cited 2×
“( 20 11 ) [5 7] G ro up I:”
BackgroundEmergence of obsessive compulsive symptoms during treatment with clozapine.
Baker, R. W., Kn, C., Baird, J. W., Steingard, S., Christ, M. A., & Nr, S. (1992) · PubMed · Cited by 156
Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder.
Saxena, S., Wang, D., Bystritsky, A., & Baxter, L. R. (1996) · PubMed · Cited by 154
de Haan, L., Sterk, B., Wouters, L. F., & LINSZEN, D. H. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr077 · Cited by 144
Billett, E. A., Richter, M. A., King, N. A., Heils, A., Lesch, K., & Kennedy, J. L. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000257 · Cited by 143
Self-citationSo, S. H., Freeman, D., Dunn, G., Kapur, S., Kuipers, E., Bebbington, P., Fowler, D., & Garety, P. A. (2012) · Journal of Abnormal Psychology · doi:10.1037/a0025297 · Cited by 143
Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder
Cavallaro, R., Cavedini, P., Mistretta, P., Bassi, T., Angelone, S. M., Ubbiali, A., & Bellodi, L. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01814-0 · Cited by 140
Skapinakis, P., Papatheodorou, T., & Mavreas, V. G. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.07.002 · Cited by 136
Clinical and Neuropsychological Profiles of Obsessive-Compulsive Schizophrenia
Hwang, M. Y., Morgan, J. E., & Losconzcy, M. F. (2000) · Journal of Neuropsychiatry · doi:10.1176/jnp.12.1.91 · Cited by 136
The Use of Aripiprazole in Obsessive-Compulsive Disorder
Connor, K. M., Payne, V., Gadde, K. M., Zhang, W., & Davidson, J. R. T. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0107 · Cited by 135
Fireman, B., Koran, L. M., Leventhal, J. L., & Jacobson, A. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1904 · Cited by 135
Carey, P. D., Vythilingum, B., Seedat, S., Muller, J. E., van Ameringen, M., & Stein, D. J. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-5 · Cited by 133
Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder
Pogarell, O. M., Hamann, C., Pöpperl, G., Juckel, G., Choukèr, M., Zaudig, M., Riedel, M. J., Möller, H., Hegerl, U., & Tatsch, K. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00183-5 · Cited by 132
Obsessive-Compulsive Disorder in Adolescent Schizophrenia Patients
Nechmad, A., Ratzoni, G., Poyurovsky, M., Meged, S., Avidan, G., Fuchs, C., Bloch, Y., & Weizman, R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.5.1002 · Cited by 132 · cited 1×
“Most studies have found that schizophrenic patients with comorbid OCS experience higher rates of positive [9, 48–51] and negative symptoms [10, 48, 51, 52], earlier age of psychosis onset [53], longer illness duration [53], use of more extensive clinical treatments [52], and longer and more frequent hospitalizations […”
BackgroundObsessive and Compulsive Symptoms in Schizophrenia: Clinical and Neurocognitive Correlates
LYSAKER, P. H., MARKS, K. A., PICONE, J. B., ROLLINS, A. L., FASTENAU, P. S., & BOND, G. R. (2000) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-200002000-00003 · Cited by 131
Öngür, D., & GOFF, D. C. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.08.012 · Cited by 126
Szekeres, G., Kéri, S., Juhász, A., Rimanóczy, Á., Szendi, I., Czimmer, C., & Janka, Z. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20045 · Cited by 126
Role of dopamine in the pathophysiology and treatment of obsessive–compulsive disorder
Koo, M.-S., Kim, E.-J., Roh, D., & Kim, C.-H. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.148 · Cited by 125
Prevalence of Obsessive-Compulsive Disorder in Schizophrenia and Significance of Motor Symptoms
Krüger, S., Bräunig, P., Höffler, J., Shugar, G., Börner, I., & Langkrär, J. (2000) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.12.1.16 · Cited by 123
Olanzapine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder
Koran, L. M., Ringold, A. L., & Elliott, M. A. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0709 · Cited by 122
Antiserotonergic antipsychotics are associated with obsessive–compulsive symptoms in schizophrenia
Schirmbeck, F., Esslinger, C., Rausch, F., Englisch, S., Meyer-Lindenberg, A., & Zink, M. (2011) · Psychological Medicine · doi:10.1017/s0033291711000419 · Cited by 117
Overview of genetics and obsessive–compulsive disorder
Nicolini, H., Arnold, P. D., Nestadt, G., Lanzagorta, N., & Kennedy, J. L. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.10.011 · Cited by 116
Clozapine and Obsessions in Patients With Recent-Onset Schizophrenia and Other Psychotic Disorders
de Haan, L., LINSZEN, D. H., & Gorsira, R. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0603 · Cited by 115
Obsessive-Compulsive Symptoms During Treatment With Olanzapine and Risperidone
de Haan, L., Beuk, N., Hoogenboom, B., Dingemans, P. M. A. J., & LINSZEN, D. H. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0203 · Cited by 108
Khullar, A., Chue, P. S., & Tibbo, P. G. (2001) · PubMed Central · Cited by 107
Meira‐Lima, I., Shavitt, R. G., Miguita, K., Ikenaga, E., Miguel, E. C., & Vallada, H. (2004) · Genes, Brain and Behavior · doi:10.1046/j.1601-1848.2003.0042.x · Cited by 106
Association of Obsessions and Compulsions in Schizophrenia With Neurocognition and Negative Symptoms
Lysaker, P. H., BRYSON, G. J., Marks, K. A., Greig, T. C., & Bell, M. D. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.4.449 · Cited by 105
Kwon, J. S., Joo, Y. H., Nam, H. J., Lim, M., Cho, E.-Y., Jung, M. H., Choi, J.-S., Kim, B., Kang, D.-H., Oh, S., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.155 · Cited by 104
Describing an Atypical Antipsychotic: Receptor Binding and Its Role in Pathophysiology
Stahl, S. M. (2003) · The Primary Care Companion to The Journal of Clinical Psychiatry · Cited by 103
Weiss, E. L., Potenza, M. N., McDougle, C. J., & Epperson, C. N. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0804 · Cited by 101
Second-generation antipsychotics for obsessive compulsive disorder
Komossa, K., Depping, A. M., Meyer, M., Kissling, W., & Leucht, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008141.pub2 · Cited by 96
Tümkaya, S., Karadağ, F., Oğuzhanoğlu, N. K., Tekkanat, Ç., Varma, G. S., Özdel, O. İ., & Ateşçi, F. Ç. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.07.031 · Cited by 94
Kordon, A., Wahl, K., Koch, N., Zurowski, B., Anlauf, M., Vielhaber, K., Kahl, K. G., Broocks, A., Voderholzer, U., & Hohagen, F. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318185e735 · Cited by 92
Leonard, H. L., Meyer, M. C., Swedo, S. E., RICHTER, D., Hamburger, S. D., Allen, A. J., Rapoport, J. L., & Tucker, E. E. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199511000-00012 · Cited by 91
Obsessive‐compulsive symptoms in schizophrenia: Prevalance and clinical correlates
KAYAHAN, B., OZTURK, O., VEZNEDAROGLU, B., & ERASLAN, D. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01373.x · Cited by 88
Lin, S., Su, S.-F., & Pan, C. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000211801.66569.80 · Cited by 87
Risperidone-Induced Obsessive-Compulsive Symptoms: A Series of Six Cases
Alevizos, B., Lykouras, L., Zervas, I. M., & Christodoulou, G. N. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200210000-00004 · Cited by 84
Suicidality in schizophrenic patients with and without obsessive-compulsive disorder
Sevinçok, L., Akoğlu, A., & Kökcü, F. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.09.023 · Cited by 83
Clinical profile of “schizo-obsessive” disorder: a comparative study
Rajkumar, R. P., Reddy, Y. C. J., & Thennarasu, K. (2007) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2007.09.006 · Cited by 82
The serotonin hypothesis of obsessive compulsive disorder1
Barr, L. C., Goodman, W. K., & Price, L. H. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199311002-00011 · Cited by 80
Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms?
Sareen, J., Kirshner, A., Lander, M., Kjernisted, K. D., Eleff, M. K., & Reiss, J. P. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.03.011 · Cited by 79
Bokor, G., & Anderson, P. D. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014521996 · Cited by 79
Mukhopadhaya, K., Krishnaiah, R., Taye, T., Nigam, A., Bailey, A., Sivakumaran, T., & Fineberg, N. A. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089582 · Cited by 74
Clozapine-Induced Obsessive-Compulsive Syndromes Improve in Combination With Aripiprazole
Englisch, S., Esslinger, C., Inta, D., Weinbrenner, A., Peus, V., Gutschalk, A., Schirmbeck, F. N., & Zink, M. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31819cc8e6 · Cited by 73
Brandl, E. J., Tiwari, A. K., Zhou, X., Deluce, J. E., Kennedy, J. L., Müller, D., & Richter, M. A. (2013) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.12 · Cited by 72
Self-citationDorado, P., Peñas‐Lledó, E., & LLerena, A. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.11.1597 · Cited by 72
Ghaemi, S. N., Zarate, C. A., Popli, A. P., Pillay, S. S., & Cole, J. O. (1995) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(95)90071-3 · Cited by 70
Francobandiera, G. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600408 · Cited by 70
Persistence and stability of delusions over time
Appelbaum, P. S., Robbins, P. C., & Vesselinov, R. M. (2004) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2004.06.001 · Cited by 68
Cai, J., Zhang, W., Yi, Z., Lu, W., Wu, Z., Chen, J., Yu, S., Fang, Y., & Zhang, C. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3137-2 · Cited by 67
de Sá, A. R., Hounie, A. G., Sampaio, A. S., Arrais, J., Miguel, E. C., & Elkis, H. (2009) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2008.11.005 · Cited by 67
Fluvoxamine Treatment in Clozapine-Induced Obsessive-Compulsive Symptoms in Schizophrenic Patients
Poyurovsky, M., Hermesh, H., & Weizman, A. (1996) · Clinical Neuropharmacology · doi:10.1097/00002826-199619040-00003 · Cited by 67
Rationality and Schizophrenic Delusion
Gold, I., & Hohwy, J. (2000) · Mind & Language · doi:10.1111/1468-0017.00127 · Cited by 66
Reznik, I., & Sirota, P. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00004 · Cited by 66
Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia
Kopala, L. C., & Honer, W. G. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.11.1714a · Cited by 64
Obsessive-Compulsive Symptoms in Patients With Schizophrenia
Beduin, A. S., Swets, M., Machielsen, M. W. J., Korver‐Nieberg, N., & Genetic Risk and Outcome of Psychosis Investigators (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07164 · Cited by 63
Schizophrenia: from Epidemiology to Rehabilitation
Mura, G., Петретто, Д. Р., Bhat, K. M., & Carta, M. G. (2012) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/1745017901208010052 · Cited by 62 · cited 3×
“acterized by a chronic course, and according to diagnostic systems, a global lifetime prevalence rate in the range of 1-4 cases per 1000 persons [1–3].”
BackgroundOlanzapine and obsessive–compulsive symptoms
Lykouras, L., Zervas, I. M., Gournellis, R. J., Malliori, M., & Rabavilas, A. D. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00096-1 · Cited by 60
Obsessive‐compulsive symptoms in clozapine‐treated schizophrenic patients
Ertuğrul, A., Yağcioğlu, A. E. A., Eni, N., & Yazici, M. K. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01362.x · Cited by 59
Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline
Allen, L., & Tejera, C. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.1096b · Cited by 59
The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder
Goodman, W. K., McDougle, C. J., & Price, L. H. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206001-00009 · Cited by 58
Poyurovsky, M., Faragian, S., Shabeta, A., & Kosov, A. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.06.010 · Cited by 58
Do the obsessive-compulsive symptoms have an effect in schizophrenia?
Tiryaki, A., & Özkorumak, E. (2009) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2009.10.007 · Cited by 58
Prevalence of Psychotic Disorders in Patients with Obsessive-Compulsive Disorder
de Haan, L., Dudek-Hodge, C., Verhoeven, Y., & Denys, D. A. J. P. (2009) · CNS Spectrums · doi:10.1017/s1092852900020381 · Cited by 56
Mahendran, R., Liew, E., & Subramaniam, M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0408 · Cited by 55
Poyurovsky, M., Isakov, V., Hromnikov, S., Modai, I., Rauchberger, B., Schneidman, M., & Weizman, A. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199903000-00006 · Cited by 55
Lim, M., Park, D. Y., Kwon, J. S., Joo, Y. H., & Hong, K. S. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815a584c · Cited by 54
Olanzapine-Induced Obsessive-Compulsive Disorder
Mottard, J., & de la Sablonnière, J.-F. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.799 · Cited by 54
Owashi, T., Ota, A., Otsubo, T., Susa, Y., & Kamijima, K. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.08.003 · Cited by 54
Worsening of Obsessive-Compulsive Symptoms Following Treatment With Olanzapine
Morrison, D., Clark, D., Goldfrm, C. E., & Mccoy, L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.855 · Cited by 53
Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder
Aouizerate, B., Guehl, D., Cuny, E., Rougier, A., Burbaud, P., Tignol, J., & Bioulac, B. H. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a789 · Cited by 51
Glick, I. D., Poyurovsky, M., Ivanova, O., & Koran, L. M. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1202 · Cited by 51
Ryu, S., Oh, S., Cho, E., Nam, H. J., Yoo, J. H., Park, T., Joo, Y. H., Kwon, J. S., & Hong, K. S. (2011) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31242 · Cited by 51
Shioiri, T., Shinada, K., Kuwabara, H., & Someya, T. (2007) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2007.01685.x · Cited by 51
Sterk, B., Lankreijer, K., LINSZEN, D. H., & de Haan, L. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.533363 · Cited by 50
Hagen, K., Hansen, B. K. A., Joa, I., & Larsen, T. K. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-156 · Cited by 50
Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms
Poyurovsky, M., Dorfman-Etrog, P., Hermesh, H., Munitz, H., Tollefson, G. D., & Weizman, A. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015030-00006 · Cited by 49
Relationship between psychotic and obsessive compulsive symptoms in schizophrenia
Guillem, F., Satterthwaite, J., Pampoulova, T., & Stip, É. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.06.004 · Cited by 49
Schirmbeck, F., Rausch, F., Englisch, S., Eifler, S., Esslinger, C., Meyer-Lindenberg, A., & Zink, M. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112463470 · Cited by 49
Poyurovsky, M., Fuchs, C., Faragian, S., Kriss, V., Weisman, G., Pashinian, A., Weizman, R., & Weizman, A. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605101204 · Cited by 49
Obsessive–compulsive disorders
Thomsen, P. H. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0357-7 · Cited by 48
Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo.
Baker, R. W., Ames, D., Umbricht, D., Chengappa, K. N., & Schooler, N. (1996) · PubMed · Cited by 46
van Nimwegen, L. J. M., de Haan, L., van Beveren, N. J. M., Laan, W., van den Brink, W., & LINSZEN, D. H. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318166f520 · Cited by 46
Kim, S., Shin, I., Kim, J., Yang, S., Hwang, M. Y., & Yoon, J. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172755a · Cited by 44
Levkovitch, Y., Kronnenberg, Y., & Gaoni, B. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199503000-00005 · Cited by 44
Quetiapine-induced Obsessive-compulsive Symptoms: A Series of Five Cases
Stamouli, S. S., & Lykouras, L. P. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000227809.60664.6d · Cited by 43
de Haan, L., Oekeneva, A., van Amelsvoort, T., & LINSZEN, D. H. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2004.09.022 · Cited by 42
Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline
Dodt, J. E., Byerly, M., Cuadros, C., & Christensen, R. C. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.582a · Cited by 42
Müller, D. J., Brandl, E. J., Hwang, R., Tiwari, A. K., Sturgess, J. E., Zai, C. C. H., Lieberman, J. A., Kennedy, J. L., & Richter, M. A. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0327 · Cited by 38
Self-citationExacerbation of Obsessive–Compulsive Symptoms Associated with Clozapine
Eales, M. J., & Layeni, A. O. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.5.687 · Cited by 38
Kim, S., Shin, I., Kim, J., Youn, T., Yang, S., Hwang, M. Y., & Yoon, J. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318184fafd · Cited by 36
Treatment of obsessive--compulsive neurosis with haloperidol.
O'Regan, J. B. (1970) · PubMed · Cited by 35
Sertraline in the Treatment of Clozapine-Induced Obsessive-Compulsive Behavior
RAHMAN, M. S., Grace, J., Pato, M. T., & Priest, B. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1626f · Cited by 34
Emergence of obsessive--compulsive symptoms and tics during clozapine withdrawal.
Poyurovsky, M., Bergman, Y., Shoshani, D., Schneidman, M., & Weizman, A. (1998) · PubMed · Cited by 32
Doyle, M., Chorcoráin, A. N., Griffith, E., Trimble, T. J., & O’Callaghan, E. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.09.001 · Cited by 32
The Paradox of Quetiapine in Obsessive-Compulsive Disorder
Tranulis, C., Potvin, S., Gourgue, M., Leblanc, G., Mancini-Marïe, A., & Stip, E. (2005) · CNS Spectrums · doi:10.1017/s1092852900022719 · Cited by 31
Aripiprazole Improves Olanzapine-Associated Obsessive Compulsive Symptoms in Schizophrenia
Schönfelder, S., Schirmbeck, F. N., Waltereit, R., Englisch, S., & Zink, M. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31823429bd · Cited by 30
Symptom structure of antipsychotic-induced obsessive compulsive symptoms in schizophrenia patients
Kim, J. H., Ryu, S., Nam, H. J., Lim, M., Baek, J. H., Joo, Y. H., Kwon, J. S., Ha, T. H., & Hong, K. S. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.05.011 · Cited by 30 · cited 1×
“In fact, case reports most frequently implicate clozapine, olanzapine, and risperidone in mediating secondary OCS [4] which are phenomenologically similar to OCS in primary obsessive-compulsive disorder (OCD) [5].”
BackgroundReznik, I., & Sirota, P. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200005000-00005 · Cited by 28
Obsessive–compulsive symptoms with olanzapine
Alevizos, B., Papageorgiou, C., & Christodoulou, G. N. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004456 · Cited by 28
Emergence of Transient Compulsive Symptoms during Treatment with Clothiapine
Toren, P., Samuel, E., Weizman, R., Golomb, A., Eldar, S., & Laor, N. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199511000-00013 · Cited by 27
Schirmbeck, F. N., Nieratschker, V., Frank, J., Englisch, S., Rausch, F., Meyer‐Lindenberg, A., Rietschel, M., & Zink, M. (2012) · Psychiatric Genetics · doi:10.1097/ypg.0b013e328353fbee · Cited by 27
Ma, N., Tan, L., Wang, Q., Li, Z.-X., & Li, L. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2005.10.005 · Cited by 26
Aripiprazole-Induced Obsessive-Compulsive Disorder
Desarkar, P., Das, A., & Nizamie, S. H. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000270091.32286.0a · Cited by 26
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
Eryılmaz, G., Sayar, G. H., Özten, E., Gül, I. G., & Karamustafalıoğlu, O. (2013) · Annals of General Psychiatry · doi:10.1186/1744-859x-12-40 · Cited by 26
Eisen, J. L., Phillips, K. A., & Rasmussen, S. A. (1999) · Psychiatric Annals · doi:10.3928/0048-5713-19990901-08 · Cited by 26
Biondi, M., Fedele, L., Arcangeli, T., & Pancheri, P. (1999) · Psychotherapy and Psychosomatics · doi:10.1159/000012321 · Cited by 25
Ke, C. K., Yen, C., Chen, C., Yang, S., Chung, W., & Yang, M. (2004) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(09)70121-4 · Cited by 22
Obsessional Symptoms Associated with Risperidone Treatment
Mahendran, R. (1998) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679809062744 · Cited by 21
Olanzapine Augmentation of Fluoxetine in the Treatment of Refractory Obsessive-Compulsive Disorder
Potenza, M. N., Wasylink, S., Longhurst, J. G., Epperson, C. N., & McDougle, C. J. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199810000-00014 · Cited by 21
Augmentation of Clozapine with Valproic Acid for Clozapine-Induced Obsessive-Compulsive Symptoms
Zink, M., Englisch, S., Knopf, U., Kuwilsky, A., & Dreßing, H. R. (2007) · Pharmacopsychiatry · doi:10.1055/s-2007-985885 · Cited by 20
Obsessive-compulsive disorder: unearthing a hidden problem.
El‐Sayegh, S., Bea, S., & Agelopoulos, A. (2003) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.70.10.824 · Cited by 20
Özer, S., Arsava, E. M., Ertuğrul, A., & Demir, B. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.030 · Cited by 18
Effectiveness of aripiprazole in treating obsessive compulsive symptoms
Yang, K., Su, T., & Chou, Y.-H. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.10.009 · Cited by 17
Veznedaroğlu, B., Ercan, E. S., Kayahan, B., Varan, A., & Bayraktar, E. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.536 · Cited by 17
Rao, N. P., Antony, A., Raveendranathan, D., Venkatasubramanian, G., Behere, R. V., Varambally, S. S., & Gangadhar, B. N. (2010) · Journal of Ect · doi:10.1097/yct.0b013e3181ec0d64 · Cited by 16
Whole-Blood Serotonin during Clomipramine Treatment of Juvenile Obsessive—Compulsive Disorder
Hanna, G. L., Yuwiler, A., & Cantwell, D. P. (1993) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1993.3.223 · Cited by 15
Obsessive-compulsive symptoms during treatment with clozapine in a patient with schizophrenia
Cheung, E. F. C. (2001) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2001.0950g.x · Cited by 15
Development of obsessive and depressive symptoms during risperidone treatment
Panagiotis, B., Maria, G., & Arts, L. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.174.6.559a · Cited by 15
Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
Narayanaswamy, J., Kulkarni, G., & Math, S. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.100406 · Cited by 12
Improvement of obsessions and compulsions with clozapine in an individual with schizophrenia.
Addington, D., Enns, M., Moamai, J., Morehouse, R. L., Porter, A., Shrikande, S., Styra, R., & Yatham, L. (1999) · PubMed · Cited by 12
Valproic acid augmentation in clozapine‐associated hand‐washing compulsion
Canan, F., Aydınoğlu, Ü., & Sinani, G. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2012.02361.x · Cited by 11
Grassi, G., Poli, L., Cantisani, A., Righi, L., Ferrari, G., & Pallanti, S. (2013) · CNS Spectrums · doi:10.1017/s1092852913000795 · Cited by 10
Kumar, S., Ng, B., & Howie, W. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2003.01107.x · Cited by 9
Cunill, R., & Cervelló, X. C. (2011) · Springer eBooks · doi:10.1007/978-94-007-0831-0_17 · Cited by 8
Emergence of Compulsive Symptoms with Olanzapine Treatment
Mahendran, R. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.t01-9-01066.x · Cited by 8
Angelucci, F., Ricci, V., Martinotti, G., Caltagirone, C., & Bria, P. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.014 · Cited by 8
Dose-related exacerbation of obsessive–compulsive symptoms with quetiapine treatment
Chen, C., Chiu, C.-C., & Huang, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.024 · Cited by 8
Obsessive-compulsive symptoms in chronic schizophrenia: a new idea or an old belief?
Jaydeokar, S., Gore, Y., Diwan, P., Deshpande, P., & Desai, N. (1997) · Europe PMC (PubMed Central) · Cited by 8
Clozapine Induced Obsessions Treated with Sertraline in an Adolescent with Schizophrenia
Coşkun, M., & Zoroglu, S. S. (2009) · Psychiatry and Clinical Psychopharmacology · Cited by 7
Nguyen, M. L., Shapiro, M. A., & Welch, S. J. (2012) · Journal of Behavioral Addictions · doi:10.1556/jba.1.2012.2.6 · Cited by 2
(1999) · The Canadian Journal of Psychiatry · doi:10.1177/070674379904401012 · Cited by 1
Research works printed but not linked: 1
- Aggarwal A, Sharma D, Sharma R, Kumar R. Obsessive-compulsive symptoms following clozapine administration. Prim Psychiatry. 2010;17(3):58–9.
Cited by
The neural underpinnings of cognitive flexibility and their disruption in psychotic illness
Waltz, J. A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.005 · Cited by 122
“…picture suggests that increasing available serotonin (through SSRI administration), can be used to successfully reduce compulsivity (Goddard et al., 2008), whereas reducing 5HT transmission, with 5HT receptor antagonists, can induce compulsivity (Schirmbeck et al., 2013, Fonseka et al., 2014).”
BackgroundTreatment-resistant OCD: Pharmacotherapies in adults
van Roessel, P., Grassi, G., Aboujaoude, E. N., Menchón, J. M., Ameringen, M. V., & Rodríguez, C. I. (2022) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2022.152352 · Cited by 112
Zike, I. D., Xu, T., Hong, N., & Veenstra-VanderWeele, J. M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.09.012 · Cited by 87
“…system may be a way to reveal the worsened symptoms that have been reported with certain drugs in OCD patients, including clozapine, stimulants, and sumatriptan and its analogs (Broocks et al., 1998, Koran et al., 2001b, Gross-Isseroff et al., 2004, Bloch et al., 2009, Fonseka et al., 2014).”
BackgroundResultPampaloni, I., Marriott, S., Pessina, E., Fisher, C., Govender, A., Mohamed, H., Chandler, A., Tyagi, H., Morris, L., & Pallanti, S. (2022) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2022.152342 · Cited by 107
Obsessive–compulsive disorder comorbid with schizophrenia and bipolar disorder
Reddy, Y. C. J., & Sharma, L. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_527_18 · Cited by 84
“Clozapine is most frequently associated with exacerbation of or de novo emergence of OCS in schizophrenia,[44,46,47] although there are few contrary reports.”
BackgroundResult
Metadata
- Authors
- Fonseka, T. M., Richter, M. A., & Müller, D. J.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Müller, Daniel J.
- Venue
- Current Psychiatry Reports
- Published
- 2014-09-26
- Volume
- 16
- Issue
- 11
- Pages
- 510-510
- ISSN
- 1523-3812 (ISSN-L)
- 1535-1645
- OpenAlex
- W2002363278
- Cited by
- 93
- References
- 186
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 9 · 2023: 9 · 2022: 10 · 2021: 7 · 2020: 9 · 2019: 5 · 2018: 9 · 2017: 4 · 2016: 9 · 2015: 5
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Psychiatry Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- atypical antipsychotics, obsessive-compulsive symptoms, schizophrenia, clozapine, olanzapine, risperidone, pharmacogenetics, treatment duration, serum drug concentration, adverse drug reactions, symptom exacerbation
- MeSH terms
- Humans, Obsessive-Compulsive Disorder, Schizophrenia, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.